ITC.NS

ITC Limited

NSI · Consumer Defensive

₹268.00

-₹2.15 (-0.80%)down -0.80%

24 September 2026 · delayed 15+ min

F

Quality score56.0 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

ITC Limited earns a F on excellent profit margins (>20%) and RSI in healthy range (30-70) but high debt-to-equity ratio (>2.0) and negative revenue growth. Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · ₹400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in rupees.

IQ-ITC.NS-20260924engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

₹256.50

Today's price

₹268.00

Lowest analyst target

₹270.00

Mean analyst target

₹327.00

52-week high

₹426.40

Highest analyst target

₹440.00

ITC.NS trades 7% of the way up its 52-week range, between ₹256.50 and ₹426.40. The mean analyst target of ₹327.00 is 22.0% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); High debt-to-equity ratio (>2.0); Negative revenue growth 35.023%

Profit margin

25.94%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

24.87%

Before interest and tax

healthyWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

The operations themselves are comfortably profitable.

Gross margin

58.28%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Debt to equity

3.29

Borrowings against equity

conservativeWhat this means

Borrowings measured against shareholder capital.

Comfortably financed.

Revenue growth

-11.10%

Year on year

shrinkingWhat this means

Change in revenue against the same period last year.

Revenue is falling, which puts every margin under pressure.

Earnings growth

-16.00%

Year on year

fallingWhat this means

Change in earnings against the same period last year.

Profit is declining even if revenue is not.

Revenue

₹76,488 Cr

Trailing twelve months

Payout ratio

91.54%

Dividends as a share of earnings

above earningsWhat this means

The share of earnings paid out as dividends.

The dividend exceeds profit, so it is being funded from cash or debt — rarely sustainable.

Growth & momentumLow volatility; Low Sharpe ratio (0.37) 50.022%

Sharpe ratio

0.37

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

50.00%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.04%

Best day

5.50%

Worst day

-9.71%

Valuation9 measured figures 60.018%

P/E ratio

16.93

Price against trailing earnings

moderateWhat this means

You pay 16.93 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

15.94

Price against forecast earnings

moderateWhat this means

Price against next year's *forecast* earnings.

A conventional range.

PEG ratio

1.78

P/E adjusted for growth

fairWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Between 1 and 2 price and growth are roughly in step.

Price to book

4.63

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

4.39

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

12.32

Whole-company value against cash earnings

moderateWhat this means

Whole-company value, debt included, against cash earnings.

A conventional range.

Enterprise value

₹3.14 L Cr

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

12,53,05,17,081

Shares the profit is split across

Dividend yield

5.92%

Annual dividend against price

meaningfulWhat this means

Annual dividend as a percentage of the share price.

A substantial part of the total return arrives as income.

TechnicalRSI in healthy range (30-70); MACD bullish (positive histogram) 60.015%

RSI (14)

54.5

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

-1.82

Momentum against its own trend

MACD histogram

1.18

Positive is bullish

RiskLow volatility risk 60.012%

Volatility, annualised

19.88%

How far it swings in a year

calmWhat this means

How far the price typically swings over a year.

Steadier than the broad market's long-run average.

Beta

-0.09

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-44.93%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

Moderate

The engine's own banding

Analyst viewAnalyst consensus: Buy; Significant upside potential (22.0%) 100.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

33

Mean price target

₹327.00

Highest target

₹440.00

Lowest target

₹270.00

Implied upside

22.01%

Target against today's price

meaningfulWhat this means

How far the mean analyst target sits above today's price.

Analysts see real room above today's price.

Price against the NIFTY 50

180 trading days to 2026-09-24

ITC.NS is nan% down over the window, against 9.4% down for the NIFTY 50 — behind by nan points.
ITC.NS +nan%NIFTY 50 -9.4%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-08, so they can be compared directly.
DateCloseITC.NS rebasedNIFTY 50 rebased
2026-01-08₹325.05100.0100.0
2026-01-30₹307.1794.597.9
2026-02-20₹318.3397.998.8
2026-03-16₹300.0792.390.5
2026-04-09₹295.9690.791.9
2026-05-01₹307.5594.3—
2026-05-22₹294.7090.491.7
2026-06-12₹285.1087.791.3
2026-07-03₹290.9589.293.8
2026-07-24₹283.4587.291.8
2026-08-14₹278.2085.694.2
2026-09-04₹264.1081.292.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health35.023%8.1
Growth & momentum50.022%11.0
Valuation60.018%10.8
Technical60.015%9.0
Risk60.012%7.2
Analyst view100.010%10.0
ESG50.00%0.0
Quality score100%56.0

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

56.0 / 100

Identical to the IQInvest grade.

All 44 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
52-week highMarket data₹426.40Yahoo Finance
52-week lowMarket data₹256.50Yahoo Finance
Analysts coveringAnalyst view33Yahoo Finance
Average daily returnGrowth & momentum0.04%Yahoo Finance
Average volumeMarket data1,41,87,134Yahoo Finance
Best dayGrowth & momentum5.50%Yahoo Finance
BetaRisk-0.09Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Day highMarket data₹270.30Yahoo Finance
Day lowMarket data₹267.70Yahoo Finance
Debt to equityFinancial health3.29Yahoo Finance
Dividend yieldValuation5.92%Yahoo Finance
Earnings growthFinancial health-16.00%Yahoo Finance
EmployeesMarket data22,493Yahoo Finance
Enterprise valueValuation₹3.14 L CrYahoo Finance
EV / EBITDAValuation12.32Yahoo Finance
Forward P/EValuation15.94Yahoo Finance
Gross marginFinancial health58.28%Yahoo Finance
Highest targetAnalyst view₹440.00Yahoo Finance
Implied upsideAnalyst view22.01%Yahoo Finance
Lowest targetAnalyst view₹270.00Yahoo Finance
MACDTechnical-1.82Yahoo Finance
MACD histogramTechnical1.18Yahoo Finance
Maximum drawdownRisk-44.93%Yahoo Finance
Mean price targetAnalyst view₹327.00Yahoo Finance
OpenMarket data₹269.70Yahoo Finance
Operating marginFinancial health24.87%Yahoo Finance
P/E ratioValuation16.93Yahoo Finance
Payout ratioFinancial health91.54%Yahoo Finance
PEG ratioValuation1.78Yahoo Finance
Previous closeMarket data₹270.15Yahoo Finance
Price to bookValuation4.63Yahoo Finance
Price to salesValuation4.39Yahoo Finance
Profit marginFinancial health25.94%Yahoo Finance
RevenueFinancial health₹76,488 CrYahoo Finance
Revenue growthFinancial health-11.10%Yahoo Finance
Risk categoryRiskModerateYahoo Finance
RSI (14)Technical54.5Yahoo Finance
Shares outstandingValuation12,53,05,17,081Yahoo Finance
Sharpe ratioGrowth & momentum0.37Yahoo Finance
Volatility, annualisedRisk19.88%Yahoo Finance
VolumeMarket data73,15,136Yahoo Finance
Win rateGrowth & momentum50.00%Yahoo Finance
Worst dayGrowth & momentum-9.71%Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more